In a cohort study of 123 COVID-19 male patients, an increasing antisperm IgA and IgG antibodies in the semen were observed, with significant seminiferous tubular injury, reduced Leydig cells, and mild lymphocytic inflammation [10]. This evidence concerns the gene CD79A and COVID-19.